首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1813332

分子診斷：技術與全球市場

Molecular Diagnostics: Technologies and Global Markets

出版日期: 2025年09月04日 | 出版商:

BCC Research | 英文 142 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球分子診斷市場預計將從2025年的230億美元成長到2030年底的426億美元，在2025-2030年預測期內的年複合成長率為 13.1%。

預計北美分子診斷市場在預測期（2025-2030年）將以12.5%的年複合成長率成長，從2025年的96億美元成長到2030年底的173億美元。

預計歐洲分子診斷市場將從2025年的63億美元成長到2030年底的119億美元，預測期內（2025-2030年）的年複合成長率為 13.6%。

調查範圍

本報告對全球分子診斷市場進行了全面的研究，包括市場規模分析、製造商產品和策略的詳細分析以及基於技術、產品/服務、應用和地區的細分。

本報告調查分子診斷市場並分析了市場趨勢。報告提供了基準年2024年的全球收益（百萬美元），並對預測期從2025年到2030年底進行了估算。市場依產品/服務類型、應用、技術和地區進行細分。根據產品/服務類型，市場進一步細分為消耗品、儀器、軟體和服務。根據技術，市場細分為聚合酵素鏈鎖反應（PCR）、次世代定序（NGS）、原位雜合反應（ICH）、微陣列和其他。根據應用，市場細分為感染疾病、腫瘤學、產前和產後檢測、身份和親子鑑定和其他。

本報告還重點關注北美、歐洲、亞太地區和世界其他地區的市場區域細分，並重點關注這些地區的主要國家。報告重點介紹了影響市場和供應商格局的關鍵驅動趨勢和挑戰。報告分析了環境、社會和治理（ESG）發展情況，並討論了與市場相關的專利和新興技術。

報告最後對競爭格局和行業結構進行了分析，還包括一個專門的公司簡介部分，詳細介紹了主要企業。

報告內容

95個資料表和 54個附加表
全球分子診斷市場概況與分析
全球市場趨勢分析，包括2022年至2024年的歷史收益資料、2025年的估計和預測以及2030年的年複合成長率預測
依產品/服務類型、技術、應用和地區進行市場佔有率分析，以及全球市場規模和收益預測的估計
有關市場動態、機會和阻礙因素、技術進步、法規和宏觀經濟變數影響的事實和資料
波特五力模型與全球供應鏈分析的見解
評估現有產品、進行臨床試驗並確定新產品和檢測方法開發的新潛在市場
專利分析重點突出已授權和已公佈的關鍵專利
概述產業永續性趨勢和 ESG 發展，重點在於主要企業實施的ESG 實踐、ESG評級和消費者意識
產業結構分析，包括企業市場占有率和排名、策略聯盟、併購和創業融資前景
主要企業簡介包括 F. Hoffmann-La Roche Ltd.、Danaher Corp.、Biomerieux、Exact Sciences Corp. 和 Hologic Inc.

細分市場
依技術進行市場分析
關鍵要點
聚合酵素鏈鎖反應（PCR）
次世代定序（NGS）
原位雜合技術
微陣列
其他
依產品/服務進行市場分析
關鍵要點
耗材
裝置
軟體和服務
依應用進行市場分析
關鍵要點
感染疾病
腫瘤學
產前和產後篩檢
身份識別和親子鑑定
其他
地理分佈
區域市場分析
關鍵要點
北美洲
歐洲
亞太地區
其他地區

第6章競爭訊息

關鍵要點
產業結構
分子診斷市場企業市場占有率分析
戰略分析

第7章分子診斷市場的永續性：ESG 視角

第8章附錄

調查方法
來源
簡稱
公司簡介
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
ILLUMINA INC.
MYRIAD GENETICS INC.
QIAGEN
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
新興Start-Ups/市場顛覆者

簡介目錄圖表

Product Code: BIO063F

The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.

The North American market for molecular diagnostics is expected to grow from $9.6 billion in 2025 and is projected to reach $17.3 billion by the end of 2030, at a CAGR of 12.5% during the forecast period of 2025 to 2030.

The European market for molecular diagnostics is expected to grow from $6.3 billion in 2025 and is projected to reach $11.9 billion by the end of 2030, at a CAGR of 13.6% during the forecast period of 2025 to 2030.

Report Scope

The scope of the global molecular diagnostics market study includes market size analysis and a detailed analysis of manufacturer products and strategies. The market has been segmented based on technology, product and service, application, and region.

This report provides an overview of the global market for molecular diagnostics and analyzes market trends. It includes global revenue ($ million) for the base year 2024 and estimated data for the forecast period 2025 through the end of 2030. The market is segmented based on product and service type, application, technology, and region. Further segmentation into consumables, instruments, software, and services is based on product and service type. Based on technology, the market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridization (ICH), microarrays, and others. Segmentation based on application includes infectious diseases, oncology, pre-and post-natal testing, identity/paternity testing, and others.

The report also focuses on regional segmentation of the market. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World (RoW), focusing on major countries in these regions. The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape and industry structure. It also includes a dedicated section of company profiles with details about leading manufacturers.

Report Includes

95 data tables and 54 additional tables
An overview and analysis of the global markets for molecular diagnostics technologies
Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
Estimates of the size and revenue prospects for the global market, along with a market share analysis by product and service type, technology, application and region
Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
Insights derived from Porter's Five Forces model and global supply chain analyses
An assessment of current products, clinical trials and identification of new potential markets for novel products and assay development
Patent analysis, featuring key granted and published patents
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Danaher Corp., Biomerieux, Exact Sciences Corp., and Hologic Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Clinical Applications of Molecular Diagnostics
Porter's Five Forces Analysis in the Market for Molecular Diagnostics
Potential for New Entrants (Moderate)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (High)
Threat of Substitute Products (Low)
Industry Rivalry (High)
Macroeconomic Factor Analysis
U.S. Tariffs
Increasing Healthcare Expenditures

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increasing Prevalence of Infectious Diseases
Growing Need for Early Detection of Chronic Diseases
Market Restraints
Regulatory Barriers
High Equipment and Testing Costs
Market Opportunities
Point-of-Care Testing
Companion Diagnostics for Targeted Therapies

Chapter 4 Emerging Technologies

Key Takeaways
Emerging Technologies
CRISPR-Based Diagnostics
Microfluidic POC Systems
Microbiome Analysis
Liquid Biopsy

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Technology
Key Takeaways
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization
Microarrays
Others
Market Analysis by Product and Service
Key Takeaways
Consumables
Instruments
Software and Services
Market Analysis by Application
Key Takeaways
Infectious Diseases
Oncology
Pre- and Post-Natal Screening
Identity and Paternity
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Key Takeaways
Industry Structure
Company Share Analysis of the Molecular Diagnostics Market
Strategic Analysis

Chapter 7 Sustainability in the Molecular Diagnostics Market: An ESG Perspective

Introduction to ESG
ESG Practices in the Molecular Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Conclusion

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
ILLUMINA INC.
MYRIAD GENETICS INC.
QIAGEN
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Emerging Start-ups/ Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Molecular Diagnostics Market, by Region, Through 2030
Table 1 : Comparison of Different Molecular Diagnostic Techniques
Table 2 : Global Molecular Diagnostics Market, by Technology, Through 2030
Table 3 : Global PCR Diagnostics Market, by Region, Through 2030
Table 4 : Global NGS Market, by Region, Through 2030
Table 5 : Global ISH Diagnostics Market, by Region, Through 2030
Table 6 : Global Microarray Diagnostics Market, by Region, Through 2030
Table 7 : Global Other Technologies Market, by Region, Through 2030
Table 8 : Global Molecular Diagnostics Market, by Product and Service, Through 2030
Table 9 : Global Molecular Diagnostic Consumables Market, by Region, Through 2030
Table 10 : Global Molecular Diagnostics Instruments Market, by Region, Through 2030
Table 11 : Global Molecular Diagnostics Software and Services Market, by Region, Through 2030
Table 12 : Global Molecular Diagnostics Market, by Application, Through 2030
Table 13 : Global Molecular Diagnostics Market for Infectious Diseases, by Region, Through 2030
Table 14 : Global Molecular Diagnostics Market for Oncology, by Region, Through 2030
Table 15 : Common Birth Defects and Their Frequency in the U.S.
Table 16 : Global Molecular Diagnostics Market for Pre- and Post-Natal Screening, by Region, Through 2030
Table 17 : Global Molecular Diagnostics Market for Identity and Paternity, by Region, Through 2030
Table 18 : Global Molecular Diagnostics Market for Other Applications, by Region, Through 2030
Table 19 : Global Molecular Diagnostics Market, by Region, Through 2030
Table 20 : North American Molecular Diagnostics Market, by Country, Through 2030
Table 21 : North American Molecular Diagnostics Market, by Technology, Through 2030
Table 22 : North American Molecular Diagnostics Market, by Product and Service, Through 2030
Table 23 : North American Molecular Diagnostics Market, by Application, Through 2030
Table 24 : U.S. Molecular Diagnostics Market, by Technology, Through 2030
Table 25 : U.S. Molecular Diagnostics Market, by Product and Service, Through 2030
Table 26 : U.S. Molecular Diagnostics Market, by Application, Through 2030
Table 27 : Canadian Molecular Diagnostics Market, by Technology, Through 2030
Table 28 : Canadian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 29 : Canadian Molecular Diagnostics Market, by Application, Through 2030
Table 30 : Mexican Molecular Diagnostics Market, by Technology, Through 2030
Table 31 : Mexican Molecular Diagnostics Market, by Product and Service, Through 2030
Table 32 : Mexican Molecular Diagnostics Market, by Application, Through 2030
Table 33 : European Molecular Diagnostics Therapeutics Market, by Country, Through 2030
Table 34 : European Molecular Diagnostics Market, by Technology, Through 2030
Table 35 : European Molecular Diagnostics Market, by Product and Service, Through 2030
Table 36 : European Molecular Diagnostics Market, by Application, Through 2030
Table 37 : German Molecular Diagnostics Market, by Technology, Through 2030
Table 38 : German Molecular Diagnostics Market, by Product and Service, Through 2030
Table 39 : German Molecular Diagnostics Market, by Application, Through 2030
Table 40 : U.K. Molecular Diagnostics Market, by Technology, Through 2030
Table 41 : U.K. Molecular Diagnostics Market, by Product and Service, Through 2030
Table 42 : U.K. Molecular Diagnostics Market, by Application, Through 2030
Table 43 : French Molecular Diagnostics Market, by Technology, Through 2030
Table 44 : French Molecular Diagnostics Market, by Product and Service, Through 2030
Table 45 : French Molecular Diagnostics Market, by Application, Through 2030
Table 46 : Italian Molecular Diagnostics Market, by Technology, Through 2030
Table 47 : Italian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 48 : Italian Molecular Diagnostics Market, by Application, Through 2030
Table 49 : Spanish Molecular Diagnostics Market, by Technology, Through 2030
Table 50 : Spanish Molecular Diagnostics Market, by Product and Service, Through 2030
Table 51 : Spanish Molecular Diagnostics Market, by Application, Through 2030
Table 52 : Rest of Europe Molecular Diagnostics Market, by Technology, Through 2030
Table 53 : Rest of Europe Molecular Diagnostics Market, by Product and Service, Through 2030
Table 54 : Rest of Europe Molecular Diagnostics Market, by Application, Through 2030
Table 55 : Asia-Pacific Molecular Diagnostics Market, by Country, Through 2030
Table 56 : Asia-Pacific Molecular Diagnostics Market, by Technology, Through 2030
Table 57 : Asia-Pacific Molecular Diagnostics Market, by Product and Service, Through 2030
Table 58 : Asia-Pacific Molecular Diagnostics Market, by Application, Through 2030
Table 59 : Chinese Molecular Diagnostics Market, by Technology, Through 2030
Table 60 : Chinese Molecular Diagnostics Market, by Product and Service, Through 2030
Table 61 : Chinese Molecular Diagnostics Market, by Application, Through 2030
Table 62 : Indian Molecular Diagnostics Market, by Technology, Through 2030
Table 63 : Indian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 64 : Indian Molecular Diagnostics Market, by Application, Through 2030
Table 65 : Japanese Molecular Diagnostics Market, by Technology, Through 2030
Table 66 : Japanese Molecular Diagnostics Market, by Product and Service, Through 2030
Table 67 : Japanese Molecular Diagnostics Market, by Application, Through 2030
Table 68 : South Korean Molecular Diagnostics Market, by Technology, Through 2030
Table 69 : South Korean Molecular Diagnostics Market, by Product and Service, Through 2030
Table 70 : South Korean Molecular Diagnostics Market, by Application, Through 2030
Table 71 : Australian Molecular Diagnostics Market, by Technology, Through 2030
Table 72 : Australian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 73 : Australian Molecular Diagnostics Market, by Application, Through 2030
Table 74 : Rest of Asia-Pacific Molecular Diagnostics Market, by Technology, Through 2030
Table 75 : Rest of Asia-Pacific Molecular Diagnostics Market, by Product and Service, Through 2030
Table 76 : Rest of Asia-Pacific Molecular Diagnostics Market, by Application, Through 2030
Table 77 : RoW Molecular Diagnostics Market, by Sub-Region, Through 2030
Table 78 : RoW Molecular Diagnostics Market, by Technology, Through 2030
Table 79 : RoW Molecular Diagnostics Market, by Product and Service, Through 2030
Table 80 : RoW Molecular Diagnostics Market, by Application, Through 2030
Table 81 : Recent Developments in the Molecular Diagnostics Market, 2022-2025
Table 82 : Environmental Performance Initiatives in the Molecular Diagnostics Market
Table 83 : Social Performance Initiatives in the Molecular Diagnostics Market
Table 84 : Governance Performance Initiatives in the Molecular Diagnostics Market
Table 85 : ESG Risk Rankings for Molecular Diagnostics Companies, 2025
Table 86 : Report Information Sources
Table 87 : Abbreviations Used in the Global Molecular Diagnostics Market
Table 88 : Abbott: Company Snapshot
Table 89 : Abbott: Financial Performance, FY 2023 and 2024
Table 90 : Abbott: Product Portfolio
Table 91 : Abbott: News/Key Developments, 2024
Table 92 : Agilent Technologies Inc.: Company Snapshot
Table 93 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 94 : Agilent Technologies Inc.: Product Portfolio
Table 95 : Agilent Technologies Inc.: News/Key Developments, 2024-2025
Table 96 : BD: Company Snapshot
Table 97 : BD: Financial Performance, FY 2023 and 2024
Table 98 : BD: Product Portfolio
Table 99 : BD: News/Key Developments, 2025
Table 100 : bioMerieux: Company Snapshot
Table 101 : bioMerieux: Financial Performance, FY 2023 and 2024
Table 102 : bioMerieux: Product Portfolio
Table 103 : bioMerieux: News/Key Developments, 2024
Table 104 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 105 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 106 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 107 : Bio-Rad Laboratories Inc.: News/Key Developments, 2025
Table 108 : Danaher Corp.: Company Snapshot
Table 109 : Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 110 : Danaher Corp.: Product Portfolio
Table 111 : Danaher Corp.: News/Key Developments, 2025
Table 112 : Exact Sciences Corp.: Company Snapshot
Table 113 : Exact Sciences Corp.: Financial Performance, FY 2023 and 2024
Table 114 : Exact Sciences Corp.: Product Portfolio
Table 115 : Exact Sciences Corp.: News/Key Developments, 2022
Table 116 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 117 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 118 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 119 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024
Table 120 : Hologic Inc.: Company Snapshot
Table 121 : Hologic Inc.: Financial Performance, FY 2023 and 2024
Table 122 : Hologic Inc.: Product Portfolio
Table 123 : Hologic Inc.: News/Key Developments, 2025
Table 124 : Illumina Inc.: Company Snapshot
Table 125 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 126 : Illumina Inc.: Product Portfolio
Table 127 : Illumina Inc.: News/Key Developments, 2025
Table 128 : Myriad Genetics Inc.: Company Snapshot
Table 129 : Myriad Genetics Inc.: Financial Performance, FY 2023 and 2024
Table 130 : Myriad Genetics Inc.: Product Portfolio
Table 131 : Myriad Genetics Inc.: News/Key Developments, 2024-2025
Table 132 : Qiagen: Company Snapshot
Table 133 : Qiagen: Financial Performance, FY 2023 and 2024
Table 134 : Qiagen: Product Portfolio
Table 135 : Qiagen: News/Key Developments, 2025
Table 136 : Revvity: Company Snapshot
Table 137 : Revvity: Financial Performance, FY 2023 and 2024
Table 138 : Revvity: Product Portfolio
Table 139 : Revvity: News/Key Developments, 2024-2025
Table 140 : Siemens Healthineers AG: Company Snapshot
Table 141 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 142 : Siemens Healthineers AG: Product Portfolio
Table 143 : Siemens Healthineers AG: News/Key Developments, 2024
Table 144 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 145 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 146 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 147 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2024
Table 148 : List of Few Emerging Startups

List of Figures

Summary Figure : Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Molecular Diagnostics Industry
Figure 2 : Market Dynamics of Global Molecular Diagnostics
Figure 3 : Emerging Technologies in the Molecular Diagnostics Market
Figure 4 : Global Molecular Diagnostics Market Shares, by Technology, 2024
Figure 5 : Global Molecular Diagnostics Market Shares, by Product and Service, 2024
Figure 6 : Global Molecular Diagnostics Market Shares, by Application, 2024
Figure 7 : Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 8 : North American Molecular Diagnostics Market Shares, by Country, 2024
Figure 9 : European Molecular Diagnostics Market Shares, by Country, 2024
Figure 10 : Asia-Pacific Molecular Diagnostics Market Shares, by Country, 2024
Figure 11 : RoW Molecular Diagnostics Market Shares, by Sub-Region, 2024
Figure 12 : Company Market Shares in Molecular Diagnostics, 2024
Figure 13 : Key ESG Metrics of Molecular Diagnostics Companies
Figure 14 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 15 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 16 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 17 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 18 : BD: Revenue Shares, by Business Unit, FY 2024
Figure 19 : BD: Revenue Shares, by Country/Region, FY 2024
Figure 20 : bioMerieux: Revenue Shares, by Business Unit, FY 2024
Figure 21 : bioMerieux: Revenue Shares, by Country/Region, FY 2024
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 23 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 24 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 25 : Danaher Corp.: Revenue Shares, by Region, FY 2024
Figure 26 : Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 27 : Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 28 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 29 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 30 : Hologic Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 31 : Hologic Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 32 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 33 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 34 : Myriad Genetics Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 35 : Myriad Genetics Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 36 : Qiagen: Revenue Shares, by Business Unit, FY 2024
Figure 37 : Qiagen: Revenue Shares, by Country/Region, FY 2024
Figure 38 : Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 39 : Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 40 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
Figure 41 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
Figure 42 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024